Luca Novara
Candiolo, 10060, Italy
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 12 publications
Evolving neoantigen profiles in colorectal cancers with DNA repair defects.
Journal: Genome medicine
Published: January 17, 2019
A Genomic Analysis Workflow for Colorectal Cancer Precision Oncology.
Journal: Clinical colorectal cancer
Published: December 14, 2018
Exploiting DNA repair defects in colorectal cancer.
Journal: Molecular oncology
Published: October 31, 2018
Patient-Derived Xenografts and Matched Cell Lines Identify Pharmacogenomic Vulnerabilities in Colorectal Cancer.
Journal: Clinical cancer research : an official journal of the American Association for Cancer Research
Published: October 20, 2018
Adaptive mutability of colorectal cancers in response to targeted therapies.
Journal: Science (New York, N.Y.)
Published: September 21, 2018
Trabectedin and olaparib in patients with advanced and non-resectable bone and soft-tissue sarcomas (TOMAS): an open-label, phase 1b study from the Italian Sarcoma Group.
Journal: The Lancet. Oncology
Published: May 03, 2018
RET fusions in a small subset of advanced colorectal cancers at risk of being neglected.
Journal: Annals of oncology : official journal of the European Society for Medical Oncology
Published: March 15, 2018
Tracking colorectal cancer evolution in time and space.
Journal: Annals of oncology : official journal of the European Society for Medical Oncology
Published: April 07, 2017
Tracking a CAD-ALK gene rearrangement in urine and blood of a colorectal cancer patient treated with an ALK inhibitor.
Journal: Annals of oncology : official journal of the European Society for Medical Oncology
Published: April 04, 2017
Loss of AXIN1 drives acquired resistance to WNT pathway blockade in colorectal cancer cells carrying RSPO3 fusions.
Journal: EMBO molecular medicine
Published: January 20, 2017
ALK, ROS1, and NTRK Rearrangements in Metastatic Colorectal Cancer.
Journal: Journal of the National Cancer Institute
Published: January 05, 2017
Acquired Resistance to the TRK Inhibitor Entrectinib in Colorectal Cancer.
Journal: Cancer discovery
Published: August 03, 2015
Showing 1-12 of 12
Last Updated: 09/26/2026